STEMI patients without standard modifiable CV risk factors face higher 30-day mortality compared with those with at least 1 risk factor.

The elderly account for the majority of medical spending in many countries, raising concerns about potentially unnecessary spending, especially during the final months of life. Using a well-defined ...

Whether a conservative strategy of medical therapy alone or a strategy of medical therapy plus invasive treatment is more beneficial in older adults with non–ST-segment elevation myocardial infarction ...

Adults hospitalized with a respiratory syncytial virus infection have an increased risk for cardiorespiratory events in the weeks afterward, according to a retrospective analysis.

The proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor evolocumab reduces the risk of major adverse cardiovascular events (MACE) among patients with a previous myocardial infarction, ...

Researchers at Kumamoto University have discovered that behavioral changes during the COVID-19 pandemic-particularly widespread mask-wearing-may have reduced the risk of certain types of heart attacks ...

Cardiologist evaluation for post-noncardiac surgery PMI patients reduces one-year risks of major adverse cardiac events and all-cause death.

Initiation of hormone therapy after age 65 years is tied to significantly increased risks for cancer and vascular events.

Research from the University of Leicester and NIHR challenges the "one-size-fits-all" approach to heart attack care, adding ...

Among nearly 180,000 females ages 15 to 24, those with prior cervical HSIL had a higher risk of cardiovascular disease (HR 1.20, 95% CI 1.15-1.24, P <0.001) compared with matched controls, reported ...